← Product Code [HIS](/submissions/OB/subpart-f%E2%80%94obstetrical-and-gynecological-therapeutic-devices/HIS) · K971132 # ROYALE BRAND LATEX CONDOMS (SILICONE)-COLORED/ASSORTED COLORS (K971132) _G. Premjee (Usa), Inc. · HIS · Sep 3, 1997 · Obstetrics/Gynecology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/OB/subpart-f%E2%80%94obstetrical-and-gynecological-therapeutic-devices/HIS/K971132 ## Device Facts - **Applicant:** G. Premjee (Usa), Inc. - **Product Code:** [HIS](/submissions/OB/subpart-f%E2%80%94obstetrical-and-gynecological-therapeutic-devices/HIS.md) - **Decision Date:** Sep 3, 1997 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 884.5300 - **Device Class:** Class 2 - **Review Panel:** Obstetrics/Gynecology ## Indications for Use The intended use of this condom is for contraception and prophylactic purposes (preventing transmission of venereal diseases). ## Device Story Royale Brand Latex Condoms are sheaths designed to cover the penis with a closely fitting membrane. The device is intended for contraception and the prevention of venereal disease transmission. It is a mechanical barrier device used by individuals for prophylactic purposes. The device is manufactured from latex and lubricated with silicone. It is intended for over-the-counter use. ## Clinical Evidence No clinical data. Bench testing only, including physical testing, air inflation testing, color fastness testing, and biocompatibility testing in accordance with ASTM D-3492-96, ISO 4074, and FDA guidance. ## Technological Characteristics Material: Latex. Lubricant: Silicone. Standards: ASTM D-3492-96, ISO 4074 (Parts 1 and 6), FDA Biocompatibility Guidance (May 1, 1995), and FDA Modified Matrix of ISO-10893. Form factor: Sheath/membrane. Shelf-life: 5 years supported by real-time testing. ## Regulatory Identification A condom is a sheath which completely covers the penis with a closely fitting membrane. The condom is used for contraceptive and for prophylactic purposes (preventing transmission of sexually transmitted infections). The device may also be used to collect semen to aid in the diagnosis of infertility. ## Special Controls *Classification.* (1) Class II (special controls) for condoms made of materials other than natural rubber latex, including natural membrane (skin) or synthetic.(2) Class II (special controls) for natural rubber latex condoms. The guidance document entitled “Class II Special Controls Guidance Document: Labeling for Natural Rubber Latex Condoms Classified Under 21 CFR 884.5300” will serve as the special control. See § 884.1(e) for the availability of this guidance document. ## Predicate Devices - Suretex Ltd., Latex Rubber Condoms (Silicone) ([K910284](/device/K910284.md)) - Sime Health Ltd., Lubricated (Silicone) Latex Condoms (Colored) (Essential™, Mi Vida™ and Jiffi™) ([K932983](/device/K932983.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0} EXHIBIT #1 K971132 P1972 # 510(K) SUMMARY This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR §807.92. The assigned 510(k) number is: _______. SEP - 3 1997 ## 1. Submitter's Identification: G. Premjee (USA) Inc. 304 B East Lawrence Blvd. Avondale, Arizona 85323 Date Summary Prepared: March 26, 1997 ## 2. Name of the Device: Royale ® Brand Latex Condoms - (Silicone)- Colored and Assorted Colors ## 3. Predicate Device Information: Suretex Ltd., K#910284, Latex Rubber Condoms (Silicone) Sime Health Ltd., K#932983, Lubricated (Silicone) Latex Condoms (Colored) (Essential™, Mi Vida™ and Jiffi™). ## 4. Device Description: A condom is a sheath which completely covers the penis with a closely fitting membrane. ## 5. Intended Use: The intended use of this condom is for contraception and prophylactic purposes (preventing transmission of venereal diseases). ## 6. Comparison to Predicate Devices: The Royale ® Brand Latex Condoms - (Silicone) - Colored or Assorted Colors, is identical in all aspects to the Suretex Ltd. Latex Rubber Condoms (Silicone) and similar in design, composition (latex) and function to the Sime Health Ltd. Lubricated (Silicone) Latex Condoms (Colored). {1} K971132 p 2072 -2- The following voluntary standards were adhered to and their device was tested in accordance with all requirements of these standards. a. ASTM-D-3492-96 b. ISO 4074, Part 1 and Part 6 c. May 1, 1995 FDA Biocompatibility Guidance, FDA Modified Matrix of ISO-10893 All physical testing, air inflation testing and color fastness testing, including all other in-process, and final release testing, revealed results that conformed to the required specifications. In addition, a shelf-life of 5 years is claimed, with real-time testing data to support such claim. 8. Discussion of Clinical Tests Performed: Not Applicable 9. Conclusions: The Royale ® Brand Latex Condoms - (Silicone) - Colored and Assorted Colors has the same intended use and similar technological characteristics as the Sime Heath Ltd. Condom and identical technological characteristics as the Suretex Ltd. Condom. All non-clinical testing and biocompatibility testing revealed no new questions of safety or effectiveness. Thus, when compared to the predicate devices, the Royale ® Brand Latex Condoms - (Silicone) - Colored and Assorted Colors did not incorporate any significant changes in intended use, method of operations, material, or design that could affect safety or effectiveness. {2} DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 G. Premjee (USA), Inc. c/o Ms. Susan D. Goldstein-Falk mdi Consultants, Inc. 55 Northern Boulevard, Suite 410 Great Neck, New York 11021 SEP - 3 1997 Re: K971132 Royale® Brand Latex Condoms (Silicone) Colored or Assorted Colors Dated: July 28, 1997 Received: July 30, 1997 Regulatory class: II 21 CFR §884.5300/Product code: 85 HIS Dear Ms. Goldstein-Falk: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, ![img-0.jpeg](img-0.jpeg) Lillian Yin, Ph.D. Director, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3} EXHIBIT B 510(k) Number (if known): Revive & Brand Latex Condoms (Silicone) - Colored or Assorted Colors Dedicated Indications For Use: The intended use of this condom is for contraception and prophylactic purposes (preventing transmission of venereal disease). (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) (Division Sign-Off) Division of Reproductive, Abdominal, ENT, and Radiological Devices 510(k) Number K971132 Prescription Use (Per 21 CFR 801.109) OR Over-The-Counter Use (Optional Format 1-2-96) --- **Source:** [https://fda.innolitics.com/submissions/OB/subpart-f%E2%80%94obstetrical-and-gynecological-therapeutic-devices/HIS/K971132](https://fda.innolitics.com/submissions/OB/subpart-f%E2%80%94obstetrical-and-gynecological-therapeutic-devices/HIS/K971132) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com